The immune response to SARS-CoV-2 in people with HIV

MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

[HTML][HTML] Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis

J Yin, Y Chen, Y Li, C Wang, X Zhang - International Journal of Infectious …, 2022 - Elsevier
Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

KS Hensley, MJ Jongkees, D Geers… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …

[HTML][HTML] Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

A Corma-Gómez, M Fernández-Fuertes… - Clinical Microbiology …, 2022 - Elsevier
Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …

Decline in antibody concentration 6 months after two doses of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients and healthy controls

SR Hamm, DL Møller, L Pérez-Alós… - Frontiers in …, 2022 - frontiersin.org
Background Previous studies have indicated inferior responses to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) …

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV–a prospective …

LD Heftdal, L Pérez-Alós, RB Hasselbalch… - …, 2023 - thelancet.com
Background We investigated long-term durability of humoral and cellular immune responses
to third dose of BNT162b2 in people with HIV (PWH) and controls. Methods In 378 PWH with …

The effect of HIV on COVID-19 vaccine responses

I Levy, G Rahav - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
The effect of HIV on COVID-19 vaccine responses : Current Opinion in HIV and AIDS The effect
of HIV on COVID-19 vaccine responses : Current Opinion in HIV and AIDS Log in or Register …

Immunogenicity and safety of COVID-19 vaccines among people living with HIV: a systematic review and meta-analysis

L Kang, W Shang, P Gao, Y Wang, J Liu, M Liu - Vaccines, 2022 - mdpi.com
Background: The immunogenicity and safety of COVID-19 vaccines among people living
with human immunodeficiency virus (PLWH) are unclear. We aimed to evaluate the …

Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles

E Touizer, A Alrubayyi, R Ford, N Hussain, PP Gerber… - Iscience, 2023 - cell.com
We assessed a cohort of people living with human immunodeficiency virus (PLWH)(n= 110)
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

Correlation between CD4 T-cell counts and seroconversion among COVID-19 vaccinated patients with HIV: a meta-analysis

Q Zhou, Y Liu, F Zeng, Y Meng, H Liu, G Deng - Vaccines, 2023 - mdpi.com
Objective: To evaluate the potential factors for predicting seroconversion due to the
coronavirus disease 2019 (COVID-19) vaccine in people living with HIV (PLWH). Method …